We explored the risk of developing a thyroid cancer by assessing serum biomarkers that are commonly measured in clinical practice and are indicative of inflammation (CRP, albumin, haptoglobin and leukocytes) in a large Swedish cohort study [17]. The gene discussed is ALB; the disease is thyroid cancer.